Patient RegistryMiraca Life Sciences
What is the Miraca Life Sciences Registry?
The Miraca Life Sciences Registry is a multi-center, observational outcomes database designed to collect data on the demographics, presentation, diagnosis, treatment, resource use, and outcomes of eligible patients who previously have undergone Miraca Life Sciences hematopoietic diagnostics testing.
By contributing patients’ data, physicians gain valuable knowledge for future patients with similar disease profiles.
Participation guidelines have been separately determined by our Registry team, pursuant to a protocol that has been approved by an independent Institutional Review Board (IRB).
How does the Miraca Life Sciences Registry work?
Detailed information from the initial hematopoietic diagnostic testing completed at Miraca Life Sciences and the patient’s outcome, collected and tracked over time, comprises the data that appears in the Registry. Patient outcome data is collected in three data intervals: enrollment, 1 year and 5 years.
Who is considered an “eligible patient”?
Bone marrow and comprehensive peripheral blood cases are eligible for enrollment into the Miraca Life Sciences Registry if the following minimum inclusion criteria are met:
- Minimum of 3 technologies
- Flow Cytometry
Participation in the registry is voluntary. All patients who meet the eligibility criteria above and who are seen within a participating physician practice are potential candidates for this registry.
The exclusion criteria for the Miraca Life Sciences Registry include the following:
- Patients < 18 years of age
- Bone marrow for staging of solid tumors